| Name | Title | Contact Details |
|---|
Aurident Inc is a Fullerton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TRANSOPTIX is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
NYU Langone Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about NYU Langone Medical Center, please visit www.nyumc.org
advantishc is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.